NCT00020917View on ClinicalTrials.gov

Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00020917 - Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | Biotech Hunter | Biotech Hunter